← Corporate WellnessHow the program works
Download PDF
Employer brief · Updated October 2026
Soothe IV Med Spa
For HR, benefits and total-rewards leaders,
and the brokers who advise them

Helping your people lose weight for good, without losing control of your plan.

The published numbers tell a simple story: the medication alone isn't the investment. The employee who feels supported enough to stay on it, lose the weight and keep it off is. Many plans are taking the medication out for 2027, so this brief spends little time on cost and most on what to put in its place. Every figure is sourced on page 2.

1The squeeze you're already living

8.2%Projected rise in health cost per employee for 2027, the largest since 2003; GLP-1 use is a full point of it, per Marsh (formerly Mercer), 1,800+ employers. 1
10.5%Share of employers' pharmacy claims now going to GLP-1s, up from 6.9% in 2023, per the International Foundation of Employee Benefit Plans. 2
57% → 53%Employers with 100+ employees covering weight-loss GLP-1s, 2025 to 2026, the first drop in three years, per WTW. 30% of those still covering may drop it. 3

You don't need a brief to tell you this is hard. Lockton, one of the largest privately held insurance brokerages in the country, puts it plainly: at current prices there is no demonstrable return within the pharmacy benefit for covering weight-loss GLP-1s. 4 Employers are acting on it for 2027: Gallagher estimates 20% to 30% of its clients dropped coverage and now send employees to the drugmakers' direct programs; WTW finds 8% have and 28% are considering it. 15 Those programs lower the price, but nobody stays with the employee afterwards. So you can't easily afford to cover it, and you can't keep telling good people no. This brief is about the third way out.

2Where the money slips away: people start, struggle alone, and stop

A prescription only pays off if the person behind it stays on it long enough to lose the weight and then keep it off. Left alone with side effects, plateaus and paperwork, most don't. 5, 6

Of every 100 employees who start a GLP-1 with no one in their corner 5, 6
30 stop within the first month
35 more stop before the year is out
35 are still on treatment at one year
By year two about 1 in 7 remains; by year three, 1 in 12. 7
Sources: Blue Health Intelligence, the Blue Cross Blue Shield data arm (first month); JAMA Network Open, 125,000 patients (one year); Prime Therapeutics claims (years two and three).
The math your claims report doesn't show. An employee who starts in January and gives up in May cost the plan five months of medication and will regain most of the weight. Every month someone stays on track is the return; the prescription is just the entry fee.
What happens to the weight after stopping 8
Lost on treatment (68 weeks) 17.3% Still off, one year after stopping 5.6% two-thirds regained
STEP 1 trial extension, Diabetes, Obesity and Metabolism.
Persistence is not fixed: one-year persistence by start year 9
33%2021 starts 61%2024 starts
Prime Therapeutics, 33,607 patients. The gain came from better side-effect management and access, which is what support between fills does.

3What keeps people on track: someone in their corner between fills

Employers have noticed. KFF, the nonprofit health-policy research organization, found that 34% of firms covering weight-loss GLP-1s now require members to work with a dietitian, case manager, therapist or lifestyle program, up from 10% a year earlier. 10 The reason is what happens on the medical side when weight actually comes off and stays off:

$1,861extra medical cost per year for an adult with obesity; about $3,100 with severe obesity (Harvard-led analysis of national data). 11
1 in 3adults with employer coverage meet the BMI criteria for these medications, so the exposure is not a rounding error. 10
Soothe IV Med Spa · Employer brief · sootheiv.com/corporate-wellnessPage 1 of 2
What companion-program vendors report (their own analyses, so treat as directional) 12, 13
67% vs 47–49%still on treatment at one year, with coaching vs. benchmark groups
63%held their weight a full year after stopping medication, with coaching continued
2.7–4.6 : 1claims-based return per dollar spent on the companion program $1 in$2.70–$4.60 back
Three questions worth asking before you fund any GLP-1 program.
  • Who is the physician? A named medical director who signs every prescription, or a platform filling orders.
  • Who calls the employee in week three? Side effects, plateaus and dosing questions are where people quit. Someone clinical has to be there.
  • What is your exposure? You should know the company's share before the year starts, and it should not grow with the dose. Through the PBM it typically runs mid-$500s to mid-$600s per user a month. 15
ApproachPersistence leverEmployer's number
Cover the drug through the PBMNone; PA and step therapyOpen-ended pharmacy spend
Exclude itNone; people self-source$0, plus turnover risk 14
Drugmakers' direct programsNone; employee is alone$0 or a reimbursement you set 15
Coaching-only vendorCoaching; low use is the weakness$65–$100 PEPM, $150+ if it prescribes 15
Supervised program with nurse follow-upClinical contact between fills; coachingA contribution you set

4The answer: a medical practice that stays with your people

We are a physician-owned medical practice. Our clinical team, under the supervision of our medical director, reviews every intake and lab, and the physician signs every prescription, all by telehealth. Then what most programs skip: a team of registered nurses and health coaches stays with each employee through treatment, managing side effects and coaching nutrition, strength and sleep so the weight stays off. Employees can join on their own or the company can contribute; HR administers nothing and gets aggregate reporting only. In Southern California, add on-site IV wellness days at no cost to HR. Your employees get a physician and a nurse who know them, and you get a number you can plan around.

5What a six-month pilot looks like

Your process comes first: broker, legal and vendor review clear before employees hear from us.

1 · First call30 minutes. You talk first: your workforce, your plan and what you've tried.
2 · Your reviewA one-page agreement, the funding choice and certificates of insurance for your broker, legal and vendor teams.
3 · AnnouncementWe write the employee email and open a private enrollment page. HR forwards it.
4 · LaunchMembers complete intake, labs and a telehealth evaluation. A nurse and health coach stay with each one.
5 · ResultsAggregate reporting at 90 and 180 days: who enrolled and who is still on track. Never an individual's health information.
Start with a 30-minute introductory call.
No slides. We listen first, then show you what fits your people and what it would take to move forward.
calendar.app.google/VCcHKHDnLTHaTnzM9
info@sootheiv.com · (949) 736-3592 · sootheiv.com/corporate-wellness

References

  1. Marsh (formerly Mercer), National Survey of Employer-Sponsored Health Plans, preliminary 2026 results: costs expected to rise 8.2% in 2027. mercer.com
  2. IFEBP, GLP-1 Drugs: 2026 Pulse Survey (U.S.) and 2025 release on GLP-1 share of claims. ifebp.org
  3. WTW, 2026 Best Practices in Healthcare Survey (471 U.S. employers with 100+ employees, fielded June 22 to August 7, 2026). wtwco.com
  4. Lockton, Why holistic GLP-1 strategies are needed now (2026). lockton.com
  5. Blue Health Intelligence, Real-world trends in GLP-1 treatment persistence (Issue Brief, 2024; ~170,000 members). bcbs.com
  6. Rodriguez PJ et al. Discontinuation and Reinitiation of Dual-Labeled GLP-1 Receptor Agonists. JAMA Network Open, 2025. jamanetwork.com
  7. Prime Therapeutics, GLP-1 persistence at two and three years (2025). primetherapeutics.com
  8. Wilding JPH et al. Weight regain after withdrawal of semaglutide: STEP 1 extension. Diabetes, Obesity and Metabolism, 2022. wiley.com
  9. Gleason PP et al. Trends in 1-year persistence among GLP-1 initiators, 2021–2024. J Managed Care & Specialty Pharmacy, 2026. jmcp.org
  10. KFF, 2025 Employer Health Benefits Survey; Peterson-KFF, Perspectives from employers on covering GLP-1s for weight loss (2025). healthsystemtracker.org
  11. Ward ZJ et al. Association of BMI with health care expenditures in the U.S. PLOS ONE, 2021. plos.org
  12. Omada Health, GLP-1 companion program outcomes (vendor-reported). omadahealth.com
  13. Wondr Health, Lessons learned: weight and GLP-1 benefits (vendor-reported). wondrhealth.com
  14. NFP, an Aon company, 2026 U.S. Benefits Trend Report. nfp.com
  15. CNBC, GLP-1 drug coverage is being dropped by employer plans (Oct. 27, 2026; Gallagher, WTW and Marsh figures). cnbc.com

Figures are quoted from the cited sources as published and are not Soothe IV Med Spa outcomes. Not medical, legal or actuarial advice. Weight-loss therapy requires a telehealth evaluation and physician clearance; not every applicant qualifies; some medications are compounded and not FDA-approved. IV wellness services are not intended to diagnose, treat, cure or prevent any disease.

Soothe IV Med Spa · 301 Bayview Cir, Ste 104-2131, Newport Beach, CA 92660 · Physician-owned & operatedPage 2 of 2

Questions employers ask about this brief

Do GLP-1 weight-loss drugs pay for themselves in an employer health plan? Not on drug spend alone at current prices. Lockton reports no demonstrable pharmacy-benefit ROI for weight-loss GLP-1 coverage. The return, where it exists, comes from members who stay on treatment long enough to lose and keep off weight, which is why persistence and clinical support decide the outcome.

How many employees stop GLP-1 medication within a year? In real-world claims, about two-thirds of adults without diabetes discontinue within a year (64.8%, JAMA Network Open, 2025), and Blue Health Intelligence found 58% stop before reaching a clinically meaningful benefit, 30% within the first month. Persistence is improving: Prime Therapeutics measured one-year persistence rising from 33% in 2021 to 61% for 2024 starts, but only about one in seven members remains on therapy at two years.

What happens to weight after someone stops a GLP-1? In the STEP 1 trial extension, participants regained two-thirds of their lost weight within one year of stopping semaglutide, with cardiometabolic measures reverting similarly. That is why a drug-only benefit with high early dropout returns little durable value to the plan.

Why are more employers requiring a companion program with GLP-1 coverage? Because the dropout drivers are clinical and manageable: unmanaged side effects, plateaus, cost and coverage loss. KFF's 2025 Employer Health Benefits Survey found 34% of firms covering weight-loss GLP-1s now require members to work with a dietitian, case manager, therapist or lifestyle program, up from 10% a year earlier. A physician-supervised program with a nurse who follows up between fills addresses the same drivers.

What does a Soothe IV Med Spa employer pilot look like? It starts with a 30-minute introductory call where the employer talks first. The employer's broker or consultant, legal and vendor teams then review a one-page agreement, the funding choice and certificates of insurance. We write the employee announcement and open a private enrollment page, members complete intake, labs and a telehealth evaluation, and a registered nurse and health coach stay with each person for six months. The employer receives aggregate reporting at 90 and 180 days, never an individual's health information.

What are employers doing about GLP-1 coverage for 2027? Many are taking it out of the plan or cutting it back. WTW's 2026 survey found coverage among employers with 100 or more employees fell from 57% to 53%, the first decline in three years, with 30% of those still covering it considering dropping it. Marsh projects health-benefit cost per employee up 8.2% in 2027, the largest increase since 2003, with rising GLP-1 use a full percentage point of that. CNBC reports that coverage typically costs employers the mid-$500s to mid-$600s per user per month, and that the common replacements are sending employees to the drugmakers' direct programs, reimbursing part of the cost outside the pharmacy benefit, or contracting a weight-management vendor at $65 to $100 per employee per month, $150 or more if it prescribes. Soothe IV Med Spa's program fits the last two: bloodwork first, every chart reviewed by our licensed medical team under our Medical Director, and a registered nurse who stays with each employee between fills, at a contribution the employer sets or on employee-pay with nothing owed by the company.

Corporate wellness overview · How the program works · Worksites & events · Download the PDF